Lilly Weight Loss Pill

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.

Viking said that an early-stage study of its obesity pill VK2735 showed adults on the highest dosage lost 8.2% of their body weight in four weeks.

Detroit News · 8d

Lilly cuts outlook on surprising weight-loss drug disappointment

Eli Lilly and Co. lowered its full-year guidance Wednesday on lackluster sales of its blockbuster weight-loss drug, a shocking miss for a drugmaker that had been going from strength to strength on insatiable demand for these drugs.

The Economist · 14d

Competition will make weight-loss drugs better, cheaper and bigger

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy,

MarketWatch on MSN · 3d

Viking Therapeutics stock jumps after ‘great’ trial of weight-loss drug

Viking Therapeutics stock rose in early trade on Monday as the company showed its oral weight-loss drug in clinical trials was successful.

Kiplinger on MSN · 3d

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

3don MSN

Viking rises after 'competitive' efficacy, safety data from oral weight-loss drug

(Reuters) -Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce ...

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not ...

STAT3d

Pharmalittle: We’re reading about a weight loss pill, the FDA warning a compounder, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

Seeking Alpha2d

How does Viking's weight loss med compare to ones from Novo, Eli Lilly?

It also has another pill, amycretin ... said it expects CagriSema and amycretin to achieve better weight loss results than Wegovy. Lilly is also developing the GIP/GLP-1/glucagon receptor ...

The Australian Financial Review1mon

Weight loss wars: a century on, the battle heats up

With the most potent weight-loss shot and a pipeline of 11 experimental treatments, including what is widely expected to be the first approved small molecule GLP-1 pill, Eli Lilly stands to be ...

Nasdaq1mon

Eli Lilly (NYSE:LLY) Eyes Broader Market for Weight-Loss Drugs

So far, the trials for Eli Lilly’s weekly anti-obesity injection, Zepbound, as well as its experimental weight-loss pill, orforglipron, have included patients with a BMI of 30 or higher ...

Wall Street Lunch: Viking Weight-Loss Pill Data Is Striking

VK2735 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly's (LLY) blockbuster weight loss drug Zepbound, ...

29d

The end of a shortage of popular weight-loss drugs may mean many people lose access to them

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results